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Introduction

Results

Methods

• Often this evaluation is limited by the inability to
obtain adequate fluid due to high fluid viscosity or
limited volume of fluid in a small or septated cyst.
• A novel method is commercially available for
measurement of CEA (RedPath Inc., Pittsburgh,
PA) that requires 75µl of fluid compared to the
amount previously required (1ml).
• The performance characteristics of this test have
not been validated in the clinical setting.

• Commercial lab used an internally-developed
cyst fluid allocation protocol to optimize
specimen utility.

• Correlation with standard analysis showed low
variability that did not affect interpretation of
results. (Figure 2)

• Immunodetection of CEA was done using
Roche Modular E170 electrochemiluminescent
immunoassay.
• Fluid dilution was not used except when sample
volumes fell below 75 microliters.
• CEA measurement by the institutional lab was
performed using similar assay but with a
standard protocol requiring high fluid volume.

• When stratified by CEA levels greater than
192ng/ml, 192<CEA>5 or 5<CEA, there was
discordance in only 1/13 patients.

Results

Objective
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• Cyst fluid carcinoembroyonic antigen (CEA) and
amylase help to discriminate neoplastic from
benign pancreatic cysts.
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• To examine the yield and diagnostic accuracy of
CEA measurement of the commercial test
compared to a standard academic institutional
laboratory.
Methods

• All fine needle aspirates were performed with a
22g needle.
Cyst Fluid aspirate

CEA, Amylase and
DNA analysis
to the commercial lab

Figure 1. Algorithm for cyst fluid analysis

Mean cyst size

Body-3, Head-7, Uncinate-3
23.46 mm (11mm -40 mm)

Fluid quantity

Mean 5.5 (< 0.5 ml- 20 ml)
Median- 3.5 ml

Mean CEA level

Institutional lab- 187.06 ng/ml
Commercial lab-186.5 ng/ml

Table 1. Cyst characteristics

> 1ml

1 ml sent to
Institutional lab (1ml)
for CEA and amylase

•Cyst characteristics were described in Table 1.
Location

• Prospectively collected aspirates of pancreatic
cyst of consecutive patients undergoing
endoscopic ultrasound (EUS) with aspiration.

< 1 ml

•13 patients underwent EUS FNA during the study
period with 8 male (mean age 71.5 years) and 5
female( mean age 63.6 years).

Remaining sample
sent to commercial lab
for CEA, amylase and
DNA analysis

• CEA levels were available for all 13 patient samples
sent to the commercial facility, the lowest volume
from the commercial lab that yielded a CEA value
was 50µl.
• In 2/13 (15%) there was insufficient fluid for CEA
analysis in the standard laboratory, despite
receiving the requisite 1ml.
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Figure 2. The Pearson correlation between CEA
measurements was 0.957, demonstrating an
excellent agreement.

Conclusion
• The novel commercial method of cyst fluid
analysis allows for accurate measurement of
cyst fluid CEA even on cyst fluid aspirates of
less than 1ml, and potentially less than 100µl of
fluid.
• This measurement tool increases the yield of
EUS FNA for pancreatic cysts, particularly for
those in whom cyst fluid volumes are small.
• By optimizing specimen handling, it is possible
to satisfy information needs more effectively
thereby contributing to more comprehensive
and better diagnosis and management.

